Authors: Mullins, DW Martins, RS Burger, CJ Elgert, KD

Citation: Dw. Mullins et al., Tumor cell-derived TGF-beta and IL-10 dysregulate paclitaxel-induced macrophage activation, J LEUK BIOL, 69(1), 2001, pp. 129-137

Authors: Mullins, DW Bullock, TNJ Colella, TA Robila, VV Engelhard, VH

Citation: Dw. Mullins et al., Immune responses to the HLA-A0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice, J IMMUNOL, 167(9), 2001, pp. 4853-4860

Authors: Bullock, TNJ Mullins, DW Colella, TA Engelhard, VH

Citation: Tnj. Bullock et al., Manipulation of avidity to improve effectiveness of adoptively transferredCD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice, J IMMUNOL, 167(10), 2001, pp. 5824-5831

Authors: Engelhard, VH Bullock, TNV Colella, TA Mullins, DW

Citation: Vh. Engelhard et al., Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use, CANCER J, 6, 2000, pp. S272-S280

Authors: Colella, TA Bullock, TNJ Russell, LB Mullins, DW Overwijk, WW Luckey, CJ Pierce, RA Restifo, NP Engelhard, VH

Citation: Ta. Colella et al., Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: Implications for tumor immunotherapy, J EXP MED, 191(7), 2000, pp. 1221-1231

Authors: Mullins, DW Burger, CJ Elgert, KD

Citation: Dw. Mullins et al., Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide, J IMMUNOL, 162(11), 1999, pp. 6811-6818